Validation of novel recipes for masking peanuts in double-blind, placebo-controlled food challenges
Introduction
The double-blind, placebo-controlled oral food challenge (DBPCFC) is the gold standard in food allergy diagnosis.1 Food masking is not always easy, as the intense flavor, color, or odor of certain foods makes it difficult for them to be adequately masked within a food matrix. Thus, it is important to use validated recipes to ensure adequate food masking during oral food challenges. Although the use of different foods for oral challenges has already been validated in previous studies,2,3 more validation recipes including some of the foods that are most often implicated in food allergies, such as peanuts, are required to conduct these tests in both young and adult patients.3
Data published in the literature4,5 describe the increasing prevalence of food allergy in recent decades, with peanut allergy being perceived as a particularly important social concern in many countries with a high prevalence of this condition.6 After the diagnosis of a peanut allergy, complete avoidance of peanuts with a view to prevent severe reactions can be difficult owing to their ubiquity and adversely affects patients’ quality of life.1,7 Because of these reasons, we believe that it is crucial to have the necessary tools to facilitate early and accurate diagnosis of this allergy to introduce peanuts into the diet of patients who tolerate this food. Hence, the aim of this study is to develop and validate masking recipes for placebo-controlled oral food challenges with peanuts.
Section snippets
Food Matrices: Ingredients and Preparation
There were 2 types of products containing the masked peanuts and other ingredients with low allergenic potential that were prepared—cookies and a custard-type dessert. The allergen was included in both matrices in the form of peanut flour (ML2351, Common-baits FUTTERMITTEL/Preise inkl. MwSt., Deutschland).
Adjustment of the Formulations to Obtain Cookies of Similar Appearance and Texture
The flours used were selected based on their impact on the cookies’ texture.8,9 Cocoa powder and coconut flakes were used to mask the color and flavor of the peanuts. The initial recipes were subsequently modified using a full factorial experimental design (8 × 3) to adjust the formulation. The factors selected for the study comprised the type of flour (level 1 = 100% chickpea flour [C], level 2 = 100% oat flour (O), level 3 = 50% O and 50% peanut flour (P), level 4 = 60% C and 40% O, level
Discussion
The interdisciplinary collaboration between the food technology experts, the selected tasters, and the allergists who participated in this research enabled the efficient masking of peanuts in 2 different types of recipes that can be used in DBPCFCs performed on adults and young people. We believe that the interest of these recipes lies in the fact that we have highlighted the clinical and health care need to develop easy-to-prepare recipes with low allergenic potential, owing to the
References (13)
- et al.
Development and validation of challenge materials for double blind, placebo-controlled food challenges in children
J Allergy Clin Immunol
(2004) - et al.
Food allergy: a review and update on epidemiology, pathogenesis, diagnosis, prevention and management
J Allergy Clin Immunol
(2018) - et al.
How much is too much? Threshold dose distributions for 5 food allergens
J Allergy Clin Immunol
(2015) - et al.
Is the prevalence of peanut allergy increasing? A 5-year follow-up study in children in Montreal
J Allergy Clin Immunol
(2009) - et al.
EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy
Allergy
(2014) - et al.
Validation of novel recipes for double-blind, placebo-controlled food challenges in children and adults
Allergy
(2011)
Cited by (0)
Dr García and Dr D'Amelio contributed equally to this work.
Disclosures: The authors have no conflicts of interest to report.
Funding: This research study has been funded by the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovación), the State Research Agency (Agencia Estatal de Investigación) under projects RTC-2015-3826-1, RTC-2016-5260-1, and RTC 2019-006977-1 and the Carlos III Health Institute (ISCIII, Instituto de Salud Carlos III), and co-founded by the European Regional Development Fund (ERDF) for Thematic Networks and Cooperative Research Centers: ARADyAL (RD16/0006/0031).